European VC firms band together to tackle continent’s lacklustre capital
The European Life Sciences Coalition (ELSC) aims to mobilise public and private investment amid concerns for the sector’s flagging funding landscape.
Investment
Medicxi unveils €500m fund for asset-centric biotechs
Sofinnova closes €650m healthcare fund for early-stage ventures
Biotechs brush off sector headwinds in venture financing rebound
MapLight’s $251m IPO sees schizophrenia drug developers on top
Bill Gates pledges $912m to combat infectious diseases amid US funding cuts
GSK plans $30bn investment for R&D in US
LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut
